European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
Independent risk factors for refractory mycoplasma pneumoniae pneumonia in children: a multivariate analysis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Guo Qi, Guo Hui, Chen Jie-Jie, Da Xian-Zong, Xu Xia
Аннотация
OBJECTIVE: To investigate the risk factors for refractory Mycoplasma pneumoniae pneumonia (RMPP) in children.
METHODS: Children with Mycoplasma pneumoniae pneumonia who were treated in our hospital from January 1, 2024 to June 1, 2025 were retrospectively collected and divided into the refractory Mycoplasma pneumoniae pneumonia group with 144 cases and the general Mycoplasma pneumoniae pneumonia (GMPP) group with 161 cases according to the occurrence of RMPP. The clinical data and serological indicators of the two groups were compared using the t-test, χ²-test and Logistic regression analysis.
RESULT: Leukocyte count (8.62 ± 4.48 vs. 9.84 ± 1.01, P = 0.002), C-reactive protein (21.64 ± 14.76 vs. 26.61 ± 6.71, P < 0.001), D-dimer (0.72 ± 0.10 vs. 1.08 ± 0.60, P < 0.001), lactate dehydrogenase (281.05 ± 80.22 vs. 326.02 ± 43.92, P < 0.001) and neutrophil-to-lymphocyte ratio (NLR, 3.11 ± 2.11 vs. 4.84 ± 0.95, P < 0.001) in the RMPP group were significantly higher than those in the GMPP group. The Clinical Pulmonary Infection Score (CPIS, OR = 2.617, 95%CI:1.603-4.273), D-dimer (OR = 9.891, 95%CI:3.848-25.426), NLR (OR = 1.865, 95%CI:1.490-2.336), presence of pulmonary rales (OR = 5.265, 95%CI:2.305-12.026), abnormal chest imaging findings (P = 0.005), complicated infections (P < 0.001) and positive drug-resistant gene loci (OR = 14.023, 95%CI:5.712-34.426) were identified as independent influencing factors for RMPP infection. NLR yielded the highest area under the curve (AUC) for predicting RMPP infection with an AUC of 0.836 (95%CI:0.788-0.885), followed by the CPIS with an AUC of 0.700 (95%CI:0.640-0.759) and D-dimer with an AUC of 0.691 (95%CI:0.620-0.762).
CONCLUSION: The CPIS, D-dimer, NLR, presence of pulmonary rales, abnormal chest imaging findings, complicated infections and positive drug-resistant gene loci are independent influencing factors for RMPP infection, and vigilance for the development of RMPP is warranted in the presence of these factors.
METHODS: Children with Mycoplasma pneumoniae pneumonia who were treated in our hospital from January 1, 2024 to June 1, 2025 were retrospectively collected and divided into the refractory Mycoplasma pneumoniae pneumonia group with 144 cases and the general Mycoplasma pneumoniae pneumonia (GMPP) group with 161 cases according to the occurrence of RMPP. The clinical data and serological indicators of the two groups were compared using the t-test, χ²-test and Logistic regression analysis.
RESULT: Leukocyte count (8.62 ± 4.48 vs. 9.84 ± 1.01, P = 0.002), C-reactive protein (21.64 ± 14.76 vs. 26.61 ± 6.71, P < 0.001), D-dimer (0.72 ± 0.10 vs. 1.08 ± 0.60, P < 0.001), lactate dehydrogenase (281.05 ± 80.22 vs. 326.02 ± 43.92, P < 0.001) and neutrophil-to-lymphocyte ratio (NLR, 3.11 ± 2.11 vs. 4.84 ± 0.95, P < 0.001) in the RMPP group were significantly higher than those in the GMPP group. The Clinical Pulmonary Infection Score (CPIS, OR = 2.617, 95%CI:1.603-4.273), D-dimer (OR = 9.891, 95%CI:3.848-25.426), NLR (OR = 1.865, 95%CI:1.490-2.336), presence of pulmonary rales (OR = 5.265, 95%CI:2.305-12.026), abnormal chest imaging findings (P = 0.005), complicated infections (P < 0.001) and positive drug-resistant gene loci (OR = 14.023, 95%CI:5.712-34.426) were identified as independent influencing factors for RMPP infection. NLR yielded the highest area under the curve (AUC) for predicting RMPP infection with an AUC of 0.836 (95%CI:0.788-0.885), followed by the CPIS with an AUC of 0.700 (95%CI:0.640-0.759) and D-dimer with an AUC of 0.691 (95%CI:0.620-0.762).
CONCLUSION: The CPIS, D-dimer, NLR, presence of pulmonary rales, abnormal chest imaging findings, complicated infections and positive drug-resistant gene loci are independent influencing factors for RMPP infection, and vigilance for the development of RMPP is warranted in the presence of these factors.